Market analysis
STIM Gapped 22.57%. Greenbrook Supplied About 94% of the Revenue Increase.
Public sources checked through November 11, 2026, at 5:28 p.m. ET.
Neuronetics opened at $2.77 on Nov. 4, up 22.57%, and closed at $2.71. Its premarket release showed quarterly revenue up 12.5% to about $42 million, with adjusted EBITDA swinging from a $4.67 million loss to a $1.89 million profit. Greenbrook supplied almost all the additional revenue. Both divisions contributed to the improvement in segment profit. Nov. 4 FennEdge recap · Premarket filing and acceptance time · Quarterly 10-Q
The clinics added $4.38 million in revenue
In the quarter ended Sept. 30, Greenbrook clinic revenue increased from $21.81 million to $26.19 million, a gain of about $4.38 million. That accounted for about 94% of the company’s $4.67 million increase. NeuroStar added about $280,000. The filing recast the year-earlier numbers under the current segment structure, so the two periods use the same reporting basis. 10-Q segment revenue tables
Both divisions helped the profit line
Greenbrook’s quarterly segment result swung from a loss of about $970,000 to a profit of $3.11 million. NeuroStar’s segment profit went from roughly $290,000 to $4.81 million, helped by a drop in direct selling and administrative expenses from $9.14 million to $6.22 million. After unallocated corporate expenses, Neuronetics reported about $540,000 of operating income, compared with a $7.32 million operating loss a year earlier. 10-Q segment expenses and consolidated operating income
The company still recorded a consolidated net loss of about $1.56 million that quarter. The Nov. 4 filing said Neuronetics complied with its loan covenants at Sept. 30, 2026, but projected that trailing twelve-month revenue could fall below the required threshold for March 31, 2027. It disclosed substantial doubt about its ability to continue as a going concern. The lender’s test is tied to the credit agreement’s revenue requirement and the company’s ability to repay. 10-Q liquidity and credit covenants
This article explains common concepts; examples are not trading recommendations.